Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes

ConditionHeart Failure

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorTor Biering-Sørensen

About this trial

The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.

Eligibility criteria

Qualifiers

Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization

Age ≥18 years

Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as "not monitored"

Disqualifiers

None

Trial design

Treatments tested in this trial

HeartLogic

Treatment groups

1,428 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Tor Biering-Sørensen

Lead sponsor

Herlev and Gentofte Hospital

Sponsor institution

Boston Scientific Corporation

Collaborator

Source ClinicalTrials.gov